CADILA HEALTHCARE LTD. - Zydus receives final approval from the USFDA for Amantadine Hydrochloride Capsules

01 Jun 2016

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated June 01, 2016 titled "Zydus receives final approval from the USFDA for Amantadine Hydrochloride Capsules".

Source: BSE India

View all announcements for CADILA HEALTHCARE LTD.

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist